Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
AKTIS ONCOLOGY INC : OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $40

AKTIS ONCOLOGY INC : OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $40

ReutersReuters2026/09/09 12:41
By:Reuters
AKTIS ONCOLOGY INC
: OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $40
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!